Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

CRDL Cardiol Therapeutics Inc

1,35

-0,07 (-4,93%)

01 Feb 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Cardiol Therapeutics (NASDAQ:CRDL)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more Cardiol Therapeutics Charts.

Cardiol Therapeutics (NASDAQ:CRDL)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more Cardiol Therapeutics Charts.

News Cardiol Therapeutics Inc

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
Donnerstag 19 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 18 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
Mittwoch 13 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 22 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 11 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 10 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Mittwoch 9 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 9 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 8 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Dienstag 8 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 24 September 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Cardiol Therapeutics Inc News-Artikel

Deutsche Telekom

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen